162. LCM-RRBS: A Novel PCR-Amplicon Based Method Compatible with Post-Mortem Samples

Daniel Almeida,Gang Chen,Naguib Mechaward,Carl Ernst,Gustavo Turecki
DOI: https://doi.org/10.1016/j.biopsych.2017.02.175
IF: 12.81
2017-01-01
Biological Psychiatry
Abstract:Throughout neurodevelopment, spatiotemporal control over gene expression by epigenetic regulation of promoters and enhancers results in a multifaceted complexity and heterogeneity of cell types within the mammalian brain. Each discrete cellular population is differentially influenced by extrinsic signals from their local environments and neighbouring cells. Thus, while a wealth of studies have investigated transcriptomic and epigenomic alterations underlying the neurobiology of psychiatric illnesses, the use of bulk-tissue homogenates have masked their ability to determine cell-type specific molecular dysfunctions. Reduced representative bisulfite sequencing (RRBS) is a widely used technique for the analysis of genome-wide methylation patterns, in regions of high CpG content, at the level of a single nucleotide. There are, however, many disadvantages associated with traditional RRBS, including its reliance on costly methylated adaptors, fragmentation of libraries during bisulfite conversion, high gDNA input requirements, as well as duplicated reads.
What problem does this paper attempt to address?